Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8220607 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 7 Pages |
Abstract
Significant changes in the multimodality management of stage I breast cancer have occurred over the past 2 decades. More favorable-risk tumors were diagnosed, and margin clearance and systemic therapy use increased. These changes contributed to the observed declining LR rates among patients treated with breast-conserving therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joycelin MD, FRCPC, Pauline T. MDCM, FRCPC, Sally L. MD, FRCPC, Linghong MSc, Mary PhD, Ivo A. MD, FRCPC,